Adult ADHD Medications and Their Cardiovascular Implications
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder exhibited by difficulty maintaining attention, as well as hyperactivity and impulsive behavior. Central nervous system (CNS) stimulants are the first line of treatment for ADHD. With the increase in number of adult...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Cardiology |
| Online Access: | http://dx.doi.org/10.1155/2016/2343691 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566822256246784 |
|---|---|
| author | A. Sinha O. Lewis R. Kumar S. L. H. Yeruva B. H. Curry |
| author_facet | A. Sinha O. Lewis R. Kumar S. L. H. Yeruva B. H. Curry |
| author_sort | A. Sinha |
| collection | DOAJ |
| description | Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder exhibited by difficulty maintaining attention, as well as hyperactivity and impulsive behavior. Central nervous system (CNS) stimulants are the first line of treatment for ADHD. With the increase in number of adults on CNS stimulants, the question that arises is how well do we understand the long-term cardiovascular effects of these drugs. There has been increasing concern that adults with ADHD are at greater risk for developing adverse cardiovascular events such as sudden death, myocardial infarction, and stroke as compared to pediatric population. Cardiovascular response attributed to ADHD medication has mainly been observed in heart rate and blood pressure elevations, while less is known about the etiology of rare cardiovascular events like acute myocardial infarction (AMI), arrhythmia, and cardiomyopathy and its long-term sequelae. We present a unique case of AMI in an adult taking Adderall (mixed amphetamine salts) and briefly discuss the literature relevant to the cardiovascular safety of CNS stimulants for adult ADHD. |
| format | Article |
| id | doaj-art-671941c1a7114de7a35144e96b2c81f9 |
| institution | Kabale University |
| issn | 2090-6404 2090-6412 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Cardiology |
| spelling | doaj-art-671941c1a7114de7a35144e96b2c81f92025-02-03T01:02:59ZengWileyCase Reports in Cardiology2090-64042090-64122016-01-01201610.1155/2016/23436912343691Adult ADHD Medications and Their Cardiovascular ImplicationsA. Sinha0O. Lewis1R. Kumar2S. L. H. Yeruva3B. H. Curry4Division of Cardiology, Saint Luke’s University Health Network, 801 Ostrum Street, Bethlehem, PA 18015, USADivision of Pulmonary Medicine, Department of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue, Washington, DC 20060, USADepartment of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue, Washington, DC 20060, USADivision of Hematology & Oncology, Department of Internal Medicine, Howard University Hospital, 2041 Georgia Avenue, Washington, DC 20060, USADivision of Cardiology, Howard University Hospital, 2041 Georgia Avenue, Washington, DC 20060, USAAttention-deficit/hyperactivity disorder (ADHD) is a chronic neurobiological disorder exhibited by difficulty maintaining attention, as well as hyperactivity and impulsive behavior. Central nervous system (CNS) stimulants are the first line of treatment for ADHD. With the increase in number of adults on CNS stimulants, the question that arises is how well do we understand the long-term cardiovascular effects of these drugs. There has been increasing concern that adults with ADHD are at greater risk for developing adverse cardiovascular events such as sudden death, myocardial infarction, and stroke as compared to pediatric population. Cardiovascular response attributed to ADHD medication has mainly been observed in heart rate and blood pressure elevations, while less is known about the etiology of rare cardiovascular events like acute myocardial infarction (AMI), arrhythmia, and cardiomyopathy and its long-term sequelae. We present a unique case of AMI in an adult taking Adderall (mixed amphetamine salts) and briefly discuss the literature relevant to the cardiovascular safety of CNS stimulants for adult ADHD.http://dx.doi.org/10.1155/2016/2343691 |
| spellingShingle | A. Sinha O. Lewis R. Kumar S. L. H. Yeruva B. H. Curry Adult ADHD Medications and Their Cardiovascular Implications Case Reports in Cardiology |
| title | Adult ADHD Medications and Their Cardiovascular Implications |
| title_full | Adult ADHD Medications and Their Cardiovascular Implications |
| title_fullStr | Adult ADHD Medications and Their Cardiovascular Implications |
| title_full_unstemmed | Adult ADHD Medications and Their Cardiovascular Implications |
| title_short | Adult ADHD Medications and Their Cardiovascular Implications |
| title_sort | adult adhd medications and their cardiovascular implications |
| url | http://dx.doi.org/10.1155/2016/2343691 |
| work_keys_str_mv | AT asinha adultadhdmedicationsandtheircardiovascularimplications AT olewis adultadhdmedicationsandtheircardiovascularimplications AT rkumar adultadhdmedicationsandtheircardiovascularimplications AT slhyeruva adultadhdmedicationsandtheircardiovascularimplications AT bhcurry adultadhdmedicationsandtheircardiovascularimplications |